Search

everythinglearnresearchcommunity

for

Search:↓

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Glucocorticoids can cause various health issues, but some treatments may help reduce these effects.

BIVV009 is a safe treatment for bullous pemphigoid that reduces C3 deposition without harmful side effects.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

Melatonin may help reduce the needed dose of prednisolone and improve hair growth in alopecia areata patients.

Cyclosporin extends hair growth in mice, but high-dose corticosteroids block this effect.

Injecting steroids like Triamcinolone Acetonide for skin treatments can cause Cushing's Syndrome.

308-nm excimer light therapy helped over a third of treatment-resistant alopecia universalis patients regrow most of their hair.

DCP therapy causes side effects like weakness, flushing, headaches, and taste changes, but less frequently causes hypertension and diabetes.

Nutrient antioxidants helped reduce prednisolone dosage and improved hair growth in alopecia areata patients.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Systemic corticosteroids can help treat rapidly spreading vitiligo but require more research for safer use.

Corticosteroids are the most effective treatment for Satoyoshi syndrome.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

Methotrexate effectively controls eye inflammation in Japanese patients with non-infectious uveitis but requires careful monitoring for side effects.

Hamilton scale imprecise, hair shaft diameter decreases, stem cell transplant regrows hair, ECP ineffective for alopecia areata universalis.

Ginger extract helps hair growth and reduces the need for prednisolone in alopecia areata patients.

A patient with Satoyoshi syndrome improved with a treatment combining several medications, including carbamazepine and methotrexate.

A young woman with late-stage Vogt-Koyanagi-Harada disease was successfully treated at a hospital.

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.

TB lymphadenitis can occur in people with SLE on long-term immunosuppressive therapy.

There is no gold standard treatment for hidradenitis suppurativa due to insufficient evidence.

A young woman with lupus developed tuberculosis due to weakened immunity from her medication, showing the need for better TB screening in such patients.

Certain hormone treatments can improve acne and related conditions in women.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

People with pemphigus are more likely to have conditions like hypothyroidism, inflammatory bowel disease, and diabetes.

Tailor treatments for vitiligo to patient needs for best results.

Antioxidants can help improve hair growth in people with alopecia areata.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

No cure exists for alopecia areata, and treatments are personalized.